PGAM
TARO

Princeton Global Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Princeton Global Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20
Closed -$1K – 625
2022
Q4 		$1K Buy
+20
New +$593 ﹤0.01% 543

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Princeton Global Asset Management's TARO Position: Q1 2023 in Review

Princeton Global Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2023, closing a stake of 20 shares — an estimated $1K sold.

Princeton Global Asset Management first reported a position in TARO in Q4 2022 and held it in 1 quarter. The position peaked at $1K in Q4 2022. 62 funds tracked by Wall St. Rank hold TARO as of Q1 2023.

  • Princeton Global Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2023 after selling out during the quarter.
  • Princeton Global Asset Management sold 20 Taro Pharmaceutical Industries Ltd. shares in Q1 2023, an estimated $1K.
  • Princeton Global Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2022 and held it in 1 quarter.
  • Princeton Global Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $1K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2023.

Based on Princeton Global Asset Management's 13F filing for Q1 2023, filed 20 Apr 2023.